The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | A global view of the challenges and unmet needs that remain in treating pediatric patients with SCD
Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, highlights the global challenges and unmet needs that remain in the treatment of pediatric patients with sickle cell disease (SCD). Dr Chakravorty emphasizes the necessity of improving access to screening and treatment programs and for patients with access to curative treatments, ensuring that the risks and benefits are accurately relayed to patients and their families. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Speaker fees from Vertex.
